New CDC Data Dashboard Shows Emerging Fentanyl and Polysubstance Use Trends

CDC’s Division of Overdose Prevention recently launched the Clinical Drug Test Dashboard. This new interactive tool provides actionable data and timely insights into trends from fentanyl, heroin, cocaine, and methamphetamine, with a focus on the primary drivers of overdose deaths.

The dashboard shows results from clinical urine drug tests ordered as part of routine care for adults diagnosed with substance use disorders. While these data do not represent drug use rates in the U.S. population, the large volume of test results can help identify national and regional changes in drug use and co-use more quickly than many traditional data sources

Learn How to Use the Dashboard

Register for our webinar on Thursday, June 11 at 1:00 p.m. EDT to walk through the dashboard, hear key findings, and get your questions answered. A recording will be posted online following the webinar.

The Dashboard Offers:

• Interactive visualizations showing available U.S. data at national and regional levels.
• Results for more than 60,000 specimens tested each quarter. Data are available from October 2023 to December 2025, representing over 650,000 specimens.
• A Key Findings page with insights and summaries from the most recent data reports.
• Clear background information on clinical urine drug tests and data collection methods.
• Guidance on common mistakes to avoid when interpreting data.

Drug tests were conducted by Millennium Health, an accredited laboratory that supports clinicians in monitoring prescription medications, detecting illegal drug use, and assessing treatment effectiveness.

The Clinical Drug Test Dashboard will be updated quarterly as new data become available. Explore the dashboard today to see what’s changing and how the data can support your overdose prevention work.